1
TÍTULO: Supplementary Figure from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTORES: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLICAÇÃO: 2023
INDEXADO EM: CrossRef
NO MEU: ORCID
2
TÍTULO: Supplementary Figure from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTORES: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLICAÇÃO: 2023
INDEXADO EM: CrossRef
NO MEU: ORCID
3
TÍTULO: Data from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTORES: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLICAÇÃO: 2023
INDEXADO EM: CrossRef
NO MEU: ORCID
4
TÍTULO: Data from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTORES: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLICAÇÃO: 2023
INDEXADO EM: CrossRef
NO MEU: ORCID
5
TÍTULO: Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTORES: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLICAÇÃO: 2022, FONTE: Clinical Cancer Research, VOLUME: 28, NÚMERO: 6
INDEXADO EM: CrossRef: 9
NO MEU: ORCID
6
TÍTULO: Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study
AUTORES: Virginia Lope; Angel Guerrero-Zotano; Emma Ruiz-Moreno; Begoña Bermejo; Silvia Antolín; Álvaro Montaño; José Manuel Baena-Cañada; Manuel Ramos Vázquez; Nerea Fernández de Larrea-Baz; José Ignacio Chacón; José Angel García-Sáenz; Clara Olier; Montserrat Muñoz; Antonio Antón; Pedro Sánchez Rovira; Angels Arcusa Lanza; Sonia González; Amparo Oltra; Joan Brunet; Joaquín Gavilá Gregori; María Teresa Martínez; Lourdes Calvo; Libertad Rosell; Susana Bezares; Roberto Pastor-Barriuso; Beatriz Pérez-Gómez; Miguel Martín; Marina Pollán; ...Mais
PUBLICAÇÃO: 2022, FONTE: Cancers, VOLUME: 14, NÚMERO: 19
INDEXADO EM: CrossRef: 3
NO MEU: ORCID